InternationalUSRemember you can easily switch between MIP US and MIP International at any time

A practical guide to interim injunctions

Fierce battles between branded and generic pharmaceutical companies have been played out in the English courts. Brian Whitehead, Stuart Jackson and Richard Kempner provide effective strategies for both obtaining and avoiding interim injunctions

Many generic pharmaceutical manufacturers have adopted a strategy of manufacturing and selling pharmaceutical products that are protected by a third party's patent. In addition to targeting and selling products protected only by formulation patents, which may be more vulnerable to...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null



July /August 2019

AI and IP: the view from above

Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable

Most read articles